Morgan Stanley Arcadia Biosciences, Inc. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.26 - $22.56 $6 - $586	26 Added 0.31%	8,496 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.56 - $22.8 $1,400 - $57,022	-2,501 Reduced 22.8%	8,470 $4,000
Q2 2022 Oct 27, 2022	SELL	$0.83 - $1.61 $5,408 - $10,490	-6,516 Reduced 37.26%	10,971 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.83 - $1.61 $5,408 - $10,490	-6,516 Reduced 37.26%	10,971 $11,000
Q1 2022 Oct 27, 2022	BUY	$0.78 - $2.62 $5,082 - $17,071	6,516 Added 59.39%	17,487 $24,000
Q1 2022 May 13, 2022	SELL	$0.78 - $2.62 $16,170 - $54,315	-20,731 Reduced 54.24%	17,487 $24,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.11 $665 - $1,403	665 Added 1.77%	38,218 $39,000
Q3 2021 Nov 15, 2021	BUY	$2.03 - $2.82 $76,232 - $105,899	37,553 New	37,553 $78,000

Ticker RKDA
Exchange NASDAQ
Sector Basic Materials
Industry Agricultural Inputs
Shares Outstandng 24,643,000
Market Cap $126M
Description
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.